1. |
Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004 [J]. CA Cancer J Clin, 2004, 54(1): 829.
|
2. |
孙备, 陈华. 胰腺癌外科治疗的现状与展望 [J].中国普外基础与临床杂志, 2008, 15(8): 547549..
|
3. |
Quest AF, GutierrezPajares JL, Torres VA. Caveolin1: an ambiguous partner in cell signalling and cancer [J]. J Cell Mol Med, 2008, 12(4): 11301150.
|
4. |
罗红梅, 唐圣松, 廖端芳, 等. Caveolin1对胃癌细胞系MGC803细胞生长的影响 [J].世界华人消化杂志, 2006, 14(15): 14481452.
|
5. |
Telang N, Katdare M. Novel cell culture model for prevention of carcinogenic risk in familial adenomatous polyposis syndrome [J]. Oncol Rep, 2009, 21(4): 10171021.
|
6. |
Kai W, Diatchenko L, Agoulnik A, et al. Caveolin1 is downregulated in human ovarian carcinoma and acts as a candidate tumor suppressor gene [J]. Am J Pathol, 2001, 159(5): 16351643.
|
7. |
Sanna E, Miotti S, Mazzi M, et al. Binding of nuclear caveolin1 to promoter elements of growthassociated genes in ovarian carcinoma cells [J]. Exp Cell Res, 2007, 313(7): 13071317.
|
8. |
Murakami S, Miyamoto M, Hida Y, et al. Caveolin1 overexpression is a favourable prognostic factor for patients with extrahepatic bile duct carcinoma [J]. Br J Cancer, 2003, 88(8): 12341238.
|
9. |
Gu D, Li H, Wang Z, et al. Caveolin1 inhibits the growth of human laryngeal squamous cell carcinoma and down regulates EGFRMAPKs signaling pathway [J]. Laryngoscope, 2007, 117(10): 17821789.
|
10. |
Wu P, Qi BJ, Zhu H, et al. Suppression of staurosporinemediated apoptosis in Hs578T breast cells through inhibition of neutralsphingomyelinase by caveolin1 [J]. Cancer Lett, 2007, 256(1): 6472.
|
11. |
Wu P, Wang X, Li F, et al. Growth suppression of MCF7 cancer cellderived xenografts in nude mice by caveolin1 [J]. Biochem Biophys Res Commun, 2008, 376(1): 215220.
|
12. |
Tanase CP, Dima S, Mihai M, et al. Caveolin1 overexpression correlates with tumour progression markers in pancreatic ductal adenocarcinoma [J]. J Mol Histol, 2009, 40(1): 2329.
|
13. |
Lin M, Divito MM, Merajver SD, et al. Regulation of pancreatic cancer cell migration and invasion by RhoC GTPase and caveolin1 [J]. Mol Cancer, 2005, 4(1): 21.
|
14. |
Fang K, Fu W, Beardsley AR, et al. Overexpression of caveolin1 inhibits endothelial cell proliferation by arresting the cell cycle at G0/G1 phase [J]. Cell Cycle, 2007, 6(2): 199204.
|
15. |
Qian N, Ueno T. Is dysfunction of caveolin1 a link between systemic sclerosis and breast cancer, opening a window on both etiologies [J]. Arch Med Res, 2010, 41(4):297301.
|
16. |
Tahir SA, Park S, Thompson TC. Caveolin1 regulates VEGFstimulated angiogenic activities in prostate cancer and endothelial cells [J]. 2009, 8(23): 22862296.
|
17. |
Liao WX, Feng L, Zhang H, et al. Compartmentalizing VEGFinduced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin1 in placental angiogenesis in vitro [J]. Mol Endocrinol, 2009, 23(9), 14281444.
|
18. |
Engelman JA, Wykoff CC, Yasuhara S, et al. Recombinant expression of caveolin1 in oncogenically transformed cells abrogates anchorageindependent growth [J]. J Biol Chem, 1997, 272(26): 1637416381.
|
19. |
Han F, Zhu HG. Caveolin1 regulating the invasion and expression of matrix metalloproteinase (MMPs) in pancreatic carcinoma cells [J]. J Surg Res, 2010, 159(1): 443450.
|
20. |
Cantley LC. The phosphoinositide 3kinase pathway [J]. Science, 2002, 296(5573): 16551657.
|
21. |
Boreddy SR, Pramanik KC, Srivastava SK. Pancreatic tumor suppression by benzyl isothiocyanate is associated with inhibition of PI3K/AKT/FOXO pathway [J]. Clin Cancer Res, 2011, 17(7): 17841795.
|
22. |
He X, Wang Y, Zhu J, et al. Resveratrol enhances the antitumor activity of the mTOR inhibitor rapamycin in multiple breast cancer cell lines mainly by suppressing rapamycininduced AKT signaling [J]. Cancer Lett, 2011, 301(2): 168176.
|
23. |
Cao P, Maira SM, Garcíaecheverría C, et al. Activity of a novel,dual PI3kinase/mTOR inhibitor NVPBEZ235 against primary human pancreatic cancers grown as orthotopic xenografts [J]. Br J Cancer, 2009, 100(8): 12671276.
|
24. |
Fujiwara M, Izuishi K, Sano T, et al. Modulating effect of the PI3kinase inhibitor LY294002 on cisplatin in human pancreatic cancer cells [J]. J Exp Clin Cancer Res, 2008, 27(1): 7684.
|
25. |
Ma J, Sawai H, Matsuo Y, et al. IGF1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF1/PI3K/Akt signaling pathway inpancreatic cancer cells [J]. J Surg Res, 2010, 160(1): 90101.
|